Abstract: The invention provides anti-CD39 antibody compositions and their use in treating cancer.

Abstract: The present disclosure relates to anti-IL-27 antibodies, and antigen-binding portions thereof. The disclosure also relates to methods for treating or ameliorating one or more symptoms of a disease, such as cancer, by administering the antibodies or antigen-binding portion thereof. The disclosure also relates to methods for detecting IL-27 in, for example, a subject or a sample.

Abstract: The invention provides anti-CD39 antibody compositions and their use in treating cancer. In some embodiments, an isolated anti-CD39 antibody is provided. Such an isolated anti-CD39 antibody binds to human CD39, wherein the antibody is optionally fully human or humanized. In some embodiments, the disclosure provides a method of enhancing, increasing and/or sustaining an anti-tumor immune response in a subject comprising administering the antibody or composition described herein to a subject having a tumor.

Abstract: The present disclosure relates to anti-IL-27 antibodies, and antigen-binding portions thereof. The disclosure also relates to methods for treating or ameliorating one or more symptoms of a disease, such as cancer, by administering the antibodies or antigen-binding portion thereof. The disclosure also relates to methods for detecting IL-27 in, for example, a subject or a sample.

Abstract: A system for defending a network against one or more cyber-threats. The system can include a network bus that includes a first node and a second node, such that network traffic flows from the first node to the second node. The system can include an intrusion defense unit connected to the network bus, such that network traffic between the first node and the second node passes through the intrusion defense unit, wherein when a potential cyber-threat is detected in the network traffic, the intrusion defense unit is configured to engage an associated switch to filter the network traffic until the cyber-threat is neutralized.

Abstract: The present disclosure relates to anti-IL-27 antibodies, and antigen-binding portions thereof. The disclosure also relates to methods for treating or ameliorating one or more symptoms of a disease, such as cancer, by administering the antibodies or antigen-binding portion thereof. The disclosure also relates to methods for detecting IL-27 in, for example, a subject or a sample.

Abstract: The present disclosure relates to anti-CD39 antibodies, and antigen binding portions thereof and their use in treating cancer.

Abstract: The invention provides anti-CD39 antibody compositions and their use in treating cancer.

Abstract: A system for defending a network against one or more cyber-threats. The system can include a network bus that includes a first node and a second node, such that network traffic flows from the first node to the second node. The system can include an intrusion defense unit connected to the network bus, such that network traffic between the first node and the second node passes through the intrusion defense unit, wherein when a potential cyber-threat is detected in the network traffic, the intrusion defense unit is configured to engage an associated switch to filter the network traffic until the cyber-threat is neutralized.

Abstract: The present disclosure relates to anti-CD39 antibodies, and antigen binding portions thereof and their use in treating cancer.

Abstract: The present disclosure relates to anti-CD39 antibodies, and antigen binding portions thereof and their use in treating cancer.

Abstract: The present disclosure relates to anti-CD39 antibodies, and antigen binding portions thereof and their use in treating cancer.

Abstract: The present disclosure relates to anti-CD39 antibodies, and antigen binding portions thereof and their use in treating cancer.

Abstract: The present disclosure relates to anti-IL-27 antibodies, and antigen-binding portions thereof. The disclosure also relates to methods for treating or ameliorating one or more symptoms of a disease, such as cancer, by administering the antibodies or antigen-binding portion thereof. The disclosure also relates to methods for detecting IL-27 in, for example, a subject or a sample.

Abstract: The present disclosure relates to anti-CD39 antibodies, and antigen binding portions thereof and their use in treating cancer.

Abstract: Disclosed are a method and device for a hanging device that is used to support ductwork, pipes, wiring, conduit and the like from support beams such as I-Joists. The disclosed embodiments take advantage of I-joist geometry and utilize the flanges of the joist to provide a quick and reliable means for securing ductwork and other elongated objects in construction projects.